Format

Send to

Choose Destination
J Exp Clin Cancer Res. 2015 Feb 15;34:17. doi: 10.1186/s13046-015-0133-x.

Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.

Author information

1
Department of Hematology, Huashan Hospital, Shanghai Medical College, Fudan University, 12 Urumqi Middle Road, 200040, Shanghai, China. wuting2011@163.com.
2
Laboratory of Molecular Biology, Training Center of Medical Experiments, School of Basic Medical Sciences, Fudan University, Shanghai, China. smwang2@fudan.edu.cn.
3
Department of Integrative Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. wujinfeng21@163.com.
4
Department of Hematology, Huashan Hospital, Shanghai Medical College, Fudan University, 12 Urumqi Middle Road, 200040, Shanghai, China. zhiguang_lin@163.com.
5
Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, China. suixianxian@163.com.
6
Department of Hematology, Huashan Hospital, Shanghai Medical College, Fudan University, 12 Urumqi Middle Road, 200040, Shanghai, China. xpxu1111@163.com.
7
Department of Virology, Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan. nshivir@mri.tmd.ac.jp.
8
Department of Hematology, Huashan Hospital, Shanghai Medical College, Fudan University, 12 Urumqi Middle Road, 200040, Shanghai, China. bbchen@fudan.edu.cn.
9
Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, 131 Dongan Road, 200032, Shanghai, China. xywang@shmu.edu.cn.

Abstract

BACKGROUND:

Extranodal NK/T-cell lymphoma (ENKL) is an aggressive hematological malignancy associated with Epstein-Barr virus (EBV) infection. It is often resistant to conventional chemotherapy and has a poor prognosis. Icaritin, a compound derived from Chinese herbal medicine, Herba Epimedii, has been reported to exert antitumor effects on a variety of cancer cell lines. In the present study, we investigated the cytotoxic effects of Icaritin on the two EBV-positive ENKL cell lines SNK-10 and SNT-8, along with the underlying molecular mechanisms.

METHODS:

ENKL cell lines SNK-10 and SNT-8 were exposed to different concentrations of Icaritin for the indicated time. Treated cells were analyzed for cell proliferation, cell cycle, and cell apoptosis. Phosphorylation of Stat3 and Akt proteins in signaling pathways and the EBV-encoded LMP1 proteins were measured by Western blot. Expression of EBV genes was assessed by Real-Time PCR.

RESULTS:

Our results showed that Icaritin dose-dependently inhibits ENKL cell proliferation and induces apoptosis and cell cycle arrest at G2/M phase. Additionally, Icaritin upregulates Bax, downregulates Bcl-2 and pBad, and activates caspase-3 and caspase-9. The anti-proliferative and pro-apoptotic effects of Icaritin are likely mediated by inhibition of Stat3 and Akt pathways through LMP1 downregulation. Importantly, Icaritin induces EBV lytic gene expression in ENKL cells, and the combination of Icaritin and the antiviral drug ganciclovir (GCV) is more effective in inducing ENKL cells apoptosis than Icaritin or GCV alone.

CONCLUSIONS:

These findings indicate that EBV-targeted approaches may have significant therapeutic potential for ENKL treatment.

PMID:
25887673
PMCID:
PMC4336495
DOI:
10.1186/s13046-015-0133-x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center